Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology

被引:0
作者
Duwe, Lea [1 ]
Fouassier, Laura [2 ]
Lafuente-Barquero, Juan [1 ]
Andersen, Jesper B. [1 ]
机构
[1] Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, Dept Hlth & Med Sci, DK-2200 Copenhagen N, Denmark
[2] Sorbonne Univ, Ctr Rech St Antoine, Inserm, CRSA, Paris, France
来源
TRANSLATIONAL ONCOLOGY | 2022年 / 26卷
基金
英国医学研究理事会;
关键词
Cholangiocarcinoma (CCA); Actin cytoskeleton; Polarization; Cell motility; Pathobiology; INTRAHEPATIC CHOLANGIOCARCINOMA; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; THERAPEUTIC TARGETS; HELICOBACTER-PYLORI; CELLULAR INVASION; POOR-PROGNOSIS; BETA-ACTIN; SINGLE-ARM; OPEN-LABEL;
D O I
10.1016/j.tranon.2022.101531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Correct actin cytoskeleton organization is vital in the liver organ homeostasis and disease control. Rearrangements of the actin cytoskeleton may play a vital role in the bile duct cells cholangiocytes. An abnormal actin network leads to aberrant cell morphology, deregulated signaling networks and ultimately triggering the development of cholangiocarcinoma (CCA) and paving the route for cancer cell dissemination (metastasis). In this review, we will outline alterations of the actin cytoskeleton and the potential role of this dynamic network in initiating CCA, as well as regulating the course of this malignancy. Actin rearrangements not only occur because of signaling pathways, but also regulate and modify cellular signaling. This emphasizes the importance of the actin cytoskeleton itself as cause for aberrant signaling and in promoting tumorigenic phenotypes. We will highlight the impact of aberrant signaling networks on the actin cytoskeleton and its rearrangement as potential cause for CCA. Often, these exact mechanisms in CCA are limited understood and still must be elucidated. Indeed, focusing future research on how actin affects and regulates other signaling pathways may provide more insights into the mechanisms of CCA development, progression, and metastasis. Moreover, manipulation of the actin cytoskeleton organization highlights the potential for a novel therapeutic area.
引用
收藏
页数:13
相关论文
共 181 条
  • [11] Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma
    Betesh, Lucy
    Comunale, Mary Ann
    Wang, Mengjun
    Liang, Hongyan
    Hafner, Julie
    Karabudak, Aykan
    Giama, Nasra H.
    Moser, Catherine D.
    Miyoshi, Eiji
    Roberts, Lewis R.
    Block, Timothy M.
    Mehta, Anand
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2017, 11 (9-10)
  • [12] Hedgehog-Stimulated Chemotaxis Is Mediated by Smoothened Located Outside the Primary Cilium
    Bijlsma, Maarten F.
    Damhofer, Helene
    Roelink, Henk
    [J]. SCIENCE SIGNALING, 2012, 5 (238)
  • [13] Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma
    Boonjaraspinyo, Sirintip
    Wu, Zhiliang
    Boonmars, Thidarut
    Kaewkes, Sasithorn
    Loilome, Watchalin
    Sithithaworn, Paiboon
    Nagano, Isao
    Takahashi, Yuzo
    Yongvanit, Puangrat
    Bhudhisawasdi, Vajarabhongsa
    [J]. PARASITOLOGY INTERNATIONAL, 2012, 61 (01) : 145 - 150
  • [14] Helicobacter pylori cag Pathogenicity Island (cagPAI) Involved in Bacterial Internalization and IL-8 Induced Responses via NOD1-and MyD88-Dependent Mechanisms in Human Biliary Epithelial Cells
    Boonyanugomol, Wongwarut
    Chomvarin, Chariya
    Hahnvajanawong, Chariya
    Sripa, Banchob
    Kaparakis-Liaskos, Maria
    Ferrero, Richard L.
    [J]. PLOS ONE, 2013, 8 (10):
  • [15] Braet F, 1996, HEPATOLOGY, V24, P627
  • [16] BUBB MR, 1994, J BIOL CHEM, V269, P14869
  • [17] Inhibition of growth and migration of cholangiocarcinoma cells by pamidronate
    Buranrat, Benjaporn
    Prawan, Auemduan
    Senggunprai, Laddawan
    Kukongviriyapan, Veerapol
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 3977 - 3983
  • [18] Platelet-Derived Growth Factor-D and Rho GTPases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcinoma
    Cadamuro, Massimiliano
    Nardo, Giorgia
    Indraccolo, Stefano
    Dall'Olmo, Luigi
    Sambado, Luisa
    Moserle, Lidia
    Franceschet, Irene
    Colledan, Michele
    Massani, Marco
    Stecca, Tommaso
    Bassi, Nicolo
    Morton, Stuart
    Spirli, Carlo
    Fiorotto, Romina
    Fabris, Luca
    Strazzabosco, Mario
    [J]. HEPATOLOGY, 2013, 58 (03) : 1042 - 1053
  • [19] Pan-cancer analysis of whole genomes
    Campbell, Peter J.
    Getz, Gad
    Korbel, Jan O.
    Stuart, Joshua M.
    Jennings, Jennifer L.
    Stein, Lincoln D.
    Perry, Marc D.
    Nahal-Bose, Hardeep K.
    Ouellette, B. F. Francis
    Li, Constance H.
    Rheinbay, Esther
    Nielsen, G. Petur
    Sgroi, Dennis C.
    Wu, Chin-Lee
    Faquin, William C.
    Deshpande, Vikram
    Boutros, Paul C.
    Lazar, Alexander J.
    Hoadley, Katherine A.
    Louis, David N.
    Dursi, L. Jonathan
    Yung, Christina K.
    Bailey, Matthew H.
    Saksena, Gordon
    Raine, Keiran M.
    Buchhalter, Ivo
    Kleinheinz, Kortine
    Schlesner, Matthias
    Zhang, Junjun
    Wang, Wenyi
    Wheeler, David A.
    Ding, Li
    Simpson, Jared T.
    O'Connor, Brian D.
    Yakneen, Sergei
    Ellrott, Kyle
    Miyoshi, Naoki
    Butler, Adam P.
    Royo, Romina
    Shorser, Solomon, I
    Vazquez, Miguel
    Rausch, Tobias
    Tiao, Grace
    Waszak, Sebastian M.
    Rodriguez-Martin, Bernardo
    Shringarpure, Suyash
    Wu, Dai-Ying
    Demidov, German M.
    Delaneau, Olivier
    Hayashi, Shuto
    [J]. NATURE, 2020, 578 (7793) : 82 - +
  • [20] Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure
    Carpino, Guido
    Overi, Diletta
    Melandro, Fabio
    Grimaldi, Alessio
    Cardinale, Vincenzo
    Di Matteo, Sabina
    Mennini, Gianluca
    Rossi, Massimo
    Alvaro, Domenico
    Barnaba, Vincenzo
    Gaudio, Eugenio
    Mancone, Carmine
    [J]. CLINICAL PROTEOMICS, 2019, 16 (01)